nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—type 2 diabetes mellitus	0.172	0.522	CbGaD
Lidocaine—CYP1A2—type 2 diabetes mellitus	0.095	0.288	CbGaD
Lidocaine—CYP3A4—type 2 diabetes mellitus	0.0629	0.191	CbGaD
Lidocaine—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0475	0.105	CbGbCtD
Lidocaine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0239	0.053	CbGbCtD
Lidocaine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0177	0.0391	CbGbCtD
Lidocaine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0141	0.0313	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0134	0.0297	CbGbCtD
Lidocaine—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0134	0.0297	CbGbCtD
Lidocaine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0134	0.0297	CbGbCtD
Lidocaine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0128	0.0283	CbGbCtD
Lidocaine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0123	0.0273	CbGbCtD
Lidocaine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.012	0.0265	CbGbCtD
Lidocaine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0118	0.0261	CbGbCtD
Lidocaine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0114	0.0252	CbGbCtD
Lidocaine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0113	0.025	CbGbCtD
Lidocaine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0105	0.0232	CbGbCtD
Lidocaine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0101	0.0223	CbGbCtD
Lidocaine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00928	0.0206	CbGbCtD
Lidocaine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00913	0.0202	CbGbCtD
Lidocaine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00891	0.0197	CbGbCtD
Lidocaine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00891	0.0197	CbGbCtD
Lidocaine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00865	0.0192	CbGbCtD
Lidocaine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00823	0.0182	CbGbCtD
Lidocaine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00815	0.018	CbGbCtD
Lidocaine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00804	0.0178	CbGbCtD
Lidocaine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00794	0.0176	CbGbCtD
Lidocaine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00752	0.0167	CbGbCtD
Lidocaine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00727	0.0161	CbGbCtD
Lidocaine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00719	0.0159	CbGbCtD
Lidocaine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00717	0.0159	CbGbCtD
Lidocaine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0068	0.015	CbGbCtD
Lidocaine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00675	0.015	CbGbCtD
Lidocaine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00656	0.0145	CbGbCtD
Lidocaine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00648	0.0143	CbGbCtD
Lidocaine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00622	0.0138	CbGbCtD
Lidocaine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00618	0.0137	CbGbCtD
Lidocaine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00598	0.0132	CbGbCtD
Lidocaine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00594	0.0132	CbGbCtD
Lidocaine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00592	0.0131	CbGbCtD
Lidocaine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00573	0.0127	CbGbCtD
Lidocaine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00518	0.0115	CbGbCtD
Lidocaine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00463	0.0103	CbGbCtD
Lidocaine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00456	0.0101	CbGbCtD
Lidocaine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00443	0.0098	CbGbCtD
Lidocaine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00417	0.00924	CbGbCtD
Lidocaine—ABCB1—Losartan—type 2 diabetes mellitus	0.00405	0.00897	CbGbCtD
Lidocaine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00393	0.0087	CbGbCtD
Lidocaine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00377	0.00834	CbGbCtD
Lidocaine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00377	0.00834	CbGbCtD
Lidocaine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00356	0.00788	CbGbCtD
Lidocaine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00265	0.00587	CbGbCtD
Lidocaine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00243	0.00537	CbGbCtD
Lidocaine—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.00156	0.0954	CbGeAlD
Lidocaine—SCN10A—nerve—type 2 diabetes mellitus	0.00122	0.0744	CbGeAlD
Lidocaine—SCN9A—nephron tubule—type 2 diabetes mellitus	0.000625	0.0381	CbGeAlD
Lidocaine—EGFR—adipose tissue—type 2 diabetes mellitus	0.000601	0.0366	CbGeAlD
Lidocaine—Procainamide—DNMT1—type 2 diabetes mellitus	0.000563	0.232	CrCbGaD
Lidocaine—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.00053	0.0323	CbGeAlD
Lidocaine—SCN9A—adipose tissue—type 2 diabetes mellitus	0.000495	0.0302	CbGeAlD
Lidocaine—SCN4A—kidney—type 2 diabetes mellitus	0.00049	0.0299	CbGeAlD
Lidocaine—SCN10A—nephron tubule—type 2 diabetes mellitus	0.000476	0.029	CbGeAlD
Lidocaine—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000454	0.0277	CbGeAlD
Lidocaine—SCN4A—adipose tissue—type 2 diabetes mellitus	0.000442	0.0269	CbGeAlD
Lidocaine—SCN2A—cortex of kidney—type 2 diabetes mellitus	0.000422	0.0257	CbGeAlD
Lidocaine—EGFR—liver—type 2 diabetes mellitus	0.000422	0.0257	CbGeAlD
Lidocaine—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000388	0.0237	CbGeAlD
Lidocaine—SCN3A—kidney—type 2 diabetes mellitus	0.000381	0.0232	CbGeAlD
Lidocaine—Levobupivacaine—CYP1A2—type 2 diabetes mellitus	0.000372	0.153	CrCbGaD
Lidocaine—SCN3A—cortex of kidney—type 2 diabetes mellitus	0.000371	0.0226	CbGeAlD
Lidocaine—CYP2C18—liver—type 2 diabetes mellitus	0.000364	0.0222	CbGeAlD
Lidocaine—CYP3A7—liver—type 2 diabetes mellitus	0.000347	0.0211	CbGeAlD
Lidocaine—SCN3A—adipose tissue—type 2 diabetes mellitus	0.000343	0.0209	CbGeAlD
Lidocaine—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000343	0.0209	CbGeAlD
Lidocaine—Bupivacaine—CYP1A2—type 2 diabetes mellitus	0.000298	0.122	CrCbGaD
Lidocaine—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000295	0.018	CbGeAlD
Lidocaine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000273	0.0166	CbGeAlD
Lidocaine—SLC22A5—retina—type 2 diabetes mellitus	0.000267	0.0163	CbGeAlD
Lidocaine—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000251	0.0153	CbGeAlD
Lidocaine—Levobupivacaine—CYP3A4—type 2 diabetes mellitus	0.000246	0.101	CrCbGaD
Lidocaine—CYP2A6—liver—type 2 diabetes mellitus	0.000241	0.0147	CbGeAlD
Lidocaine—Ropivacaine—CYP1A2—type 2 diabetes mellitus	0.00024	0.0987	CrCbGaD
Lidocaine—Tocainide—CYP1A2—type 2 diabetes mellitus	0.000225	0.0928	CrCbGaD
Lidocaine—SLC22A5—kidney—type 2 diabetes mellitus	0.000221	0.0135	CbGeAlD
Lidocaine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.00022	0.0134	CbGeAlD
Lidocaine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000218	0.0133	CbGeAlD
Lidocaine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000215	0.0131	CbGeAlD
Lidocaine—CYP2C8—kidney—type 2 diabetes mellitus	0.000214	0.013	CbGeAlD
Lidocaine—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000199	0.0121	CbGeAlD
Lidocaine—Bupivacaine—CYP3A4—type 2 diabetes mellitus	0.000197	0.081	CrCbGaD
Lidocaine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000196	0.0119	CbGeAlD
Lidocaine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000194	0.0118	CbGeAlD
Lidocaine—CYP3A5—kidney—type 2 diabetes mellitus	0.000193	0.0118	CbGeAlD
Lidocaine—CYP2B6—kidney—type 2 diabetes mellitus	0.000192	0.0117	CbGeAlD
Lidocaine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000192	0.0117	CbGeAlD
Lidocaine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000188	0.0115	CbGeAlD
Lidocaine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000174	0.0106	CbGeAlD
Lidocaine—Ropivacaine—CYP3A4—type 2 diabetes mellitus	0.000159	0.0653	CrCbGaD
Lidocaine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000145	0.00883	CbGeAlD
Lidocaine—CYP3A4—kidney—type 2 diabetes mellitus	0.000145	0.00883	CbGeAlD
Lidocaine—CYP2D6—kidney—type 2 diabetes mellitus	0.000142	0.00869	CbGeAlD
Lidocaine—SLC22A5—liver—type 2 diabetes mellitus	0.00014	0.00851	CbGeAlD
Lidocaine—CYP2C8—liver—type 2 diabetes mellitus	0.000135	0.00824	CbGeAlD
Lidocaine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000134	0.00121	CcSEcCtD
Lidocaine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000134	0.00121	CcSEcCtD
Lidocaine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000133	0.00121	CcSEcCtD
Lidocaine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000133	0.0012	CcSEcCtD
Lidocaine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000133	0.0012	CcSEcCtD
Lidocaine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000133	0.0012	CcSEcCtD
Lidocaine—Erythema—Metformin—type 2 diabetes mellitus	0.000132	0.0012	CcSEcCtD
Lidocaine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000132	0.00119	CcSEcCtD
Lidocaine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000131	0.00119	CcSEcCtD
Lidocaine—Tocainide—ALB—type 2 diabetes mellitus	0.00013	0.0536	CrCbGaD
Lidocaine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00013	0.00118	CcSEcCtD
Lidocaine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00013	0.00118	CcSEcCtD
Lidocaine—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000129	0.00117	CcSEcCtD
Lidocaine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000129	0.00117	CcSEcCtD
Lidocaine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000129	0.00117	CcSEcCtD
Lidocaine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000129	0.00117	CcSEcCtD
Lidocaine—Chills—Irbesartan—type 2 diabetes mellitus	0.000129	0.00116	CcSEcCtD
Lidocaine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000128	0.00116	CcSEcCtD
Lidocaine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000128	0.00116	CcSEcCtD
Lidocaine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000128	0.00116	CcSEcCtD
Lidocaine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000128	0.00116	CcSEcCtD
Lidocaine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000128	0.00115	CcSEcCtD
Lidocaine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000127	0.00115	CcSEcCtD
Lidocaine—CYP1A2—liver—type 2 diabetes mellitus	0.000126	0.00771	CbGeAlD
Lidocaine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000126	0.00114	CcSEcCtD
Lidocaine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000126	0.00114	CcSEcCtD
Lidocaine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000126	0.00114	CcSEcCtD
Lidocaine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000125	0.00114	CcSEcCtD
Lidocaine—Flushing—Losartan—type 2 diabetes mellitus	0.000125	0.00113	CcSEcCtD
Lidocaine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000125	0.00113	CcSEcCtD
Lidocaine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000125	0.00113	CcSEcCtD
Lidocaine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000125	0.00113	CcSEcCtD
Lidocaine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000125	0.00113	CcSEcCtD
Lidocaine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000125	0.00113	CcSEcCtD
Lidocaine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000124	0.00113	CcSEcCtD
Lidocaine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000124	0.00112	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000124	0.00112	CcSEcCtD
Lidocaine—ABCB1—retina—type 2 diabetes mellitus	0.000124	0.00755	CbGeAlD
Lidocaine—Tremor—Metformin—type 2 diabetes mellitus	0.000124	0.00112	CcSEcCtD
Lidocaine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000124	0.00112	CcSEcCtD
Lidocaine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000123	0.00112	CcSEcCtD
Lidocaine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000123	0.00111	CcSEcCtD
Lidocaine—Tension—Irbesartan—type 2 diabetes mellitus	0.000122	0.00111	CcSEcCtD
Lidocaine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000122	0.00111	CcSEcCtD
Lidocaine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000122	0.0011	CcSEcCtD
Lidocaine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000122	0.0011	CcSEcCtD
Lidocaine—CYP3A5—liver—type 2 diabetes mellitus	0.000122	0.00743	CbGeAlD
Lidocaine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000122	0.0011	CcSEcCtD
Lidocaine—CYP2B6—liver—type 2 diabetes mellitus	0.000121	0.00739	CbGeAlD
Lidocaine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000121	0.0011	CcSEcCtD
Lidocaine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00012	0.00109	CcSEcCtD
Lidocaine—CYP2C9—liver—type 2 diabetes mellitus	0.00012	0.00732	CbGeAlD
Lidocaine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000119	0.00107	CcSEcCtD
Lidocaine—Oedema—Valsartan—type 2 diabetes mellitus	0.000118	0.00107	CcSEcCtD
Lidocaine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000118	0.00107	CcSEcCtD
Lidocaine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000118	0.00107	CcSEcCtD
Lidocaine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000118	0.00107	CcSEcCtD
Lidocaine—Rash—Glipizide—type 2 diabetes mellitus	0.000118	0.00106	CcSEcCtD
Lidocaine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000118	0.00106	CcSEcCtD
Lidocaine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000117	0.00106	CcSEcCtD
Lidocaine—Erythema—Losartan—type 2 diabetes mellitus	0.000117	0.00106	CcSEcCtD
Lidocaine—Oedema—Orlistat—type 2 diabetes mellitus	0.000117	0.00106	CcSEcCtD
Lidocaine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000117	0.00106	CcSEcCtD
Lidocaine—Headache—Glipizide—type 2 diabetes mellitus	0.000117	0.00106	CcSEcCtD
Lidocaine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000117	0.00106	CcSEcCtD
Lidocaine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000117	0.00711	CbGeAlD
Lidocaine—Shock—Valsartan—type 2 diabetes mellitus	0.000116	0.00105	CcSEcCtD
Lidocaine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000116	0.00105	CcSEcCtD
Lidocaine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000116	0.00105	CcSEcCtD
Lidocaine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000116	0.00105	CcSEcCtD
Lidocaine—Tension—Losartan—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000115	0.00104	CcSEcCtD
Lidocaine—Hypertension—Metformin—type 2 diabetes mellitus	0.000114	0.00103	CcSEcCtD
Lidocaine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000114	0.00103	CcSEcCtD
Lidocaine—Nervousness—Losartan—type 2 diabetes mellitus	0.000114	0.00103	CcSEcCtD
Lidocaine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000114	0.00103	CcSEcCtD
Lidocaine—Back pain—Losartan—type 2 diabetes mellitus	0.000113	0.00103	CcSEcCtD
Lidocaine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000113	0.00102	CcSEcCtD
Lidocaine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00102	CcSEcCtD
Lidocaine—Chest pain—Metformin—type 2 diabetes mellitus	0.000112	0.00102	CcSEcCtD
Lidocaine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000112	0.00101	CcSEcCtD
Lidocaine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000111	0.00101	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000111	0.00101	CcSEcCtD
Lidocaine—Nausea—Glipizide—type 2 diabetes mellitus	0.000111	0.001	CcSEcCtD
Lidocaine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000111	0.001	CcSEcCtD
Lidocaine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000111	0.001	CcSEcCtD
Lidocaine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000111	0.001	CcSEcCtD
Lidocaine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00011	0.000998	CcSEcCtD
Lidocaine—Pain—Gliclazide—type 2 diabetes mellitus	0.00011	0.000997	CcSEcCtD
Lidocaine—Tremor—Losartan—type 2 diabetes mellitus	0.00011	0.000995	CcSEcCtD
Lidocaine—Rash—Glimepiride—type 2 diabetes mellitus	0.00011	0.000993	CcSEcCtD
Lidocaine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00011	0.000992	CcSEcCtD
Lidocaine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00011	0.000992	CcSEcCtD
Lidocaine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00099	CcSEcCtD
Lidocaine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000109	0.000989	CcSEcCtD
Lidocaine—Headache—Glimepiride—type 2 diabetes mellitus	0.000109	0.000987	CcSEcCtD
Lidocaine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000109	0.000984	CcSEcCtD
Lidocaine—Agitation—Losartan—type 2 diabetes mellitus	0.000108	0.000976	CcSEcCtD
Lidocaine—Oedema—Metformin—type 2 diabetes mellitus	0.000108	0.000976	CcSEcCtD
Lidocaine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000108	0.000975	CcSEcCtD
Lidocaine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000108	0.000974	CcSEcCtD
Lidocaine—Flushing—Ramipril—type 2 diabetes mellitus	0.000107	0.000971	CcSEcCtD
Lidocaine—Angioedema—Losartan—type 2 diabetes mellitus	0.000107	0.00097	CcSEcCtD
Lidocaine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000106	0.000962	CcSEcCtD
Lidocaine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000106	0.000961	CcSEcCtD
Lidocaine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000106	0.000961	CcSEcCtD
Lidocaine—Shock—Metformin—type 2 diabetes mellitus	0.000106	0.00096	CcSEcCtD
Lidocaine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000106	0.000957	CcSEcCtD
Lidocaine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000106	0.000957	CcSEcCtD
Lidocaine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000106	0.000957	CcSEcCtD
Lidocaine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000106	0.000955	CcSEcCtD
Lidocaine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000105	0.000953	CcSEcCtD
Lidocaine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000105	0.000951	CcSEcCtD
Lidocaine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000105	0.00639	CbGeAlD
Lidocaine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000104	0.000945	CcSEcCtD
Lidocaine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000104	0.000943	CcSEcCtD
Lidocaine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00094	CcSEcCtD
Lidocaine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000103	0.000936	CcSEcCtD
Lidocaine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000103	0.000933	CcSEcCtD
Lidocaine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000103	0.000933	CcSEcCtD
Lidocaine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000103	0.000932	CcSEcCtD
Lidocaine—ABCB1—kidney—type 2 diabetes mellitus	0.000103	0.00625	CbGeAlD
Lidocaine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000102	0.000927	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000102	0.000925	CcSEcCtD
Lidocaine—ABCB1—pancreas—type 2 diabetes mellitus	0.000102	0.00621	CbGeAlD
Lidocaine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000102	0.000921	CcSEcCtD
Lidocaine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000102	0.000921	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000101	0.000914	CcSEcCtD
Lidocaine—Hypotension—Metformin—type 2 diabetes mellitus	0.000101	0.000912	CcSEcCtD
Lidocaine—Erythema—Ramipril—type 2 diabetes mellitus	0.000101	0.000911	CcSEcCtD
Lidocaine—Shock—Irbesartan—type 2 diabetes mellitus	0.0001	0.000906	CcSEcCtD
Lidocaine—Pain—Orlistat—type 2 diabetes mellitus	0.0001	0.000905	CcSEcCtD
Lidocaine—Chest pain—Losartan—type 2 diabetes mellitus	9.99e-05	0.000904	CcSEcCtD
Lidocaine—ABCB1—cortex of kidney—type 2 diabetes mellitus	9.98e-05	0.00608	CbGeAlD
Lidocaine—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.98e-05	0.000903	CcSEcCtD
Lidocaine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.000903	CcSEcCtD
Lidocaine—Anxiety—Losartan—type 2 diabetes mellitus	9.95e-05	0.000901	CcSEcCtD
Lidocaine—Rash—Bromocriptine—type 2 diabetes mellitus	9.9e-05	0.000896	CcSEcCtD
Lidocaine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.89e-05	0.000895	CcSEcCtD
Lidocaine—Tension—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000894	CcSEcCtD
Lidocaine—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.85e-05	0.000892	CcSEcCtD
Lidocaine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.00089	CcSEcCtD
Lidocaine—Headache—Bromocriptine—type 2 diabetes mellitus	9.84e-05	0.00089	CcSEcCtD
Lidocaine—Nervousness—Ramipril—type 2 diabetes mellitus	9.77e-05	0.000884	CcSEcCtD
Lidocaine—Paraesthesia—Metformin—type 2 diabetes mellitus	9.68e-05	0.000876	CcSEcCtD
Lidocaine—Confusional state—Losartan—type 2 diabetes mellitus	9.66e-05	0.000874	CcSEcCtD
Lidocaine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.64e-05	0.000873	CcSEcCtD
Lidocaine—Dyspnoea—Metformin—type 2 diabetes mellitus	9.61e-05	0.00087	CcSEcCtD
Lidocaine—Somnolence—Metformin—type 2 diabetes mellitus	9.59e-05	0.000868	CcSEcCtD
Lidocaine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.58e-05	0.000867	CcSEcCtD
Lidocaine—Oedema—Losartan—type 2 diabetes mellitus	9.58e-05	0.000867	CcSEcCtD
Lidocaine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000861	CcSEcCtD
Lidocaine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.000859	CcSEcCtD
Lidocaine—Tremor—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000853	CcSEcCtD
Lidocaine—Shock—Losartan—type 2 diabetes mellitus	9.42e-05	0.000853	CcSEcCtD
Lidocaine—Urticaria—Valsartan—type 2 diabetes mellitus	9.41e-05	0.000851	CcSEcCtD
Lidocaine—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.39e-05	0.00085	CcSEcCtD
Lidocaine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.33e-05	0.000844	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.31e-05	0.000842	CcSEcCtD
Lidocaine—Urticaria—Orlistat—type 2 diabetes mellitus	9.29e-05	0.000841	CcSEcCtD
Lidocaine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.26e-05	0.000838	CcSEcCtD
Lidocaine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.25e-05	0.000837	CcSEcCtD
Lidocaine—Agitation—Ramipril—type 2 diabetes mellitus	9.25e-05	0.000837	CcSEcCtD
Lidocaine—ABCB1—adipose tissue—type 2 diabetes mellitus	9.24e-05	0.00563	CbGeAlD
Lidocaine—Angioedema—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000832	CcSEcCtD
Lidocaine—CYP3A4—liver—type 2 diabetes mellitus	9.15e-05	0.00558	CbGeAlD
Lidocaine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000827	CcSEcCtD
Lidocaine—Vomiting—Glyburide—type 2 diabetes mellitus	9.13e-05	0.000826	CcSEcCtD
Lidocaine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000821	CcSEcCtD
Lidocaine—Rash—Glyburide—type 2 diabetes mellitus	9.05e-05	0.000819	CcSEcCtD
Lidocaine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000819	CcSEcCtD
Lidocaine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.04e-05	0.000818	CcSEcCtD
Lidocaine—CYP2D6—liver—type 2 diabetes mellitus	9.01e-05	0.00549	CbGeAlD
Lidocaine—Headache—Glyburide—type 2 diabetes mellitus	8.99e-05	0.000814	CcSEcCtD
Lidocaine—Hypotension—Losartan—type 2 diabetes mellitus	8.95e-05	0.00081	CcSEcCtD
Lidocaine—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.89e-05	0.000804	CcSEcCtD
Lidocaine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.84e-05	0.0008	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.78e-05	0.000795	CcSEcCtD
Lidocaine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000789	CcSEcCtD
Lidocaine—Convulsion—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000789	CcSEcCtD
Lidocaine—Pain—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000787	CcSEcCtD
Lidocaine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.62e-05	0.00078	CcSEcCtD
Lidocaine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.6e-05	0.000778	CcSEcCtD
Lidocaine—Urticaria—Metformin—type 2 diabetes mellitus	8.57e-05	0.000775	CcSEcCtD
Lidocaine—Chest pain—Ramipril—type 2 diabetes mellitus	8.57e-05	0.000775	CcSEcCtD
Lidocaine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.54e-05	0.000773	CcSEcCtD
Lidocaine—Anxiety—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000773	CcSEcCtD
Lidocaine—Nausea—Glyburide—type 2 diabetes mellitus	8.53e-05	0.000772	CcSEcCtD
Lidocaine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.52e-05	0.000771	CcSEcCtD
Lidocaine—Somnolence—Losartan—type 2 diabetes mellitus	8.51e-05	0.00077	CcSEcCtD
Lidocaine—Asthenia—Valsartan—type 2 diabetes mellitus	8.5e-05	0.000769	CcSEcCtD
Lidocaine—Asthenia—Orlistat—type 2 diabetes mellitus	8.39e-05	0.00076	CcSEcCtD
Lidocaine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000759	CcSEcCtD
Lidocaine—Confusional state—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000749	CcSEcCtD
Lidocaine—Oedema—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000743	CcSEcCtD
Lidocaine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000743	CcSEcCtD
Lidocaine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.19e-05	0.000742	CcSEcCtD
Lidocaine—Pain—Losartan—type 2 diabetes mellitus	8.19e-05	0.000741	CcSEcCtD
Lidocaine—Rash—Gliclazide—type 2 diabetes mellitus	8.13e-05	0.000735	CcSEcCtD
Lidocaine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.12e-05	0.000735	CcSEcCtD
Lidocaine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.08e-05	0.000732	CcSEcCtD
Lidocaine—Shock—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000731	CcSEcCtD
Lidocaine—Headache—Gliclazide—type 2 diabetes mellitus	8.07e-05	0.000731	CcSEcCtD
Lidocaine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000729	CcSEcCtD
Lidocaine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000718	CcSEcCtD
Lidocaine—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.89e-05	0.000714	CcSEcCtD
Lidocaine—Dizziness—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000709	CcSEcCtD
Lidocaine—Dizziness—Orlistat—type 2 diabetes mellitus	7.74e-05	0.0007	CcSEcCtD
Lidocaine—Asthenia—Metformin—type 2 diabetes mellitus	7.74e-05	0.0007	CcSEcCtD
Lidocaine—Hypotension—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000694	CcSEcCtD
Lidocaine—Nausea—Gliclazide—type 2 diabetes mellitus	7.66e-05	0.000693	CcSEcCtD
Lidocaine—Urticaria—Losartan—type 2 diabetes mellitus	7.61e-05	0.000688	CcSEcCtD
Lidocaine—Vomiting—Valsartan—type 2 diabetes mellitus	7.53e-05	0.000681	CcSEcCtD
Lidocaine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000678	CcSEcCtD
Lidocaine—Rash—Valsartan—type 2 diabetes mellitus	7.47e-05	0.000676	CcSEcCtD
Lidocaine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.46e-05	0.000675	CcSEcCtD
Lidocaine—Vomiting—Orlistat—type 2 diabetes mellitus	7.44e-05	0.000673	CcSEcCtD
Lidocaine—Headache—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000671	CcSEcCtD
Lidocaine—Rash—Orlistat—type 2 diabetes mellitus	7.38e-05	0.000668	CcSEcCtD
Lidocaine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000667	CcSEcCtD
Lidocaine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.37e-05	0.000667	CcSEcCtD
Lidocaine—Headache—Orlistat—type 2 diabetes mellitus	7.33e-05	0.000663	CcSEcCtD
Lidocaine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000663	CcSEcCtD
Lidocaine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.3e-05	0.000661	CcSEcCtD
Lidocaine—Somnolence—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000661	CcSEcCtD
Lidocaine—Dizziness—Metformin—type 2 diabetes mellitus	7.13e-05	0.000645	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000642	CcSEcCtD
Lidocaine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.06e-05	0.000639	CcSEcCtD
Lidocaine—Nausea—Valsartan—type 2 diabetes mellitus	7.03e-05	0.000636	CcSEcCtD
Lidocaine—Nausea—Orlistat—type 2 diabetes mellitus	6.95e-05	0.000629	CcSEcCtD
Lidocaine—Asthenia—Losartan—type 2 diabetes mellitus	6.87e-05	0.000622	CcSEcCtD
Lidocaine—Vomiting—Metformin—type 2 diabetes mellitus	6.86e-05	0.00062	CcSEcCtD
Lidocaine—Rash—Metformin—type 2 diabetes mellitus	6.8e-05	0.000615	CcSEcCtD
Lidocaine—Dermatitis—Metformin—type 2 diabetes mellitus	6.79e-05	0.000615	CcSEcCtD
Lidocaine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000612	CcSEcCtD
Lidocaine—Headache—Metformin—type 2 diabetes mellitus	6.75e-05	0.000611	CcSEcCtD
Lidocaine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000609	CcSEcCtD
Lidocaine—Urticaria—Ramipril—type 2 diabetes mellitus	6.52e-05	0.00059	CcSEcCtD
Lidocaine—ABCB1—liver—type 2 diabetes mellitus	6.48e-05	0.00395	CbGeAlD
Lidocaine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000586	CcSEcCtD
Lidocaine—Rash—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000581	CcSEcCtD
Lidocaine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.41e-05	0.00058	CcSEcCtD
Lidocaine—Nausea—Metformin—type 2 diabetes mellitus	6.4e-05	0.00058	CcSEcCtD
Lidocaine—Headache—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000577	CcSEcCtD
Lidocaine—Dizziness—Losartan—type 2 diabetes mellitus	6.33e-05	0.000573	CcSEcCtD
Lidocaine—Vomiting—Losartan—type 2 diabetes mellitus	6.09e-05	0.000551	CcSEcCtD
Lidocaine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000547	CcSEcCtD
Lidocaine—Nausea—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.000547	CcSEcCtD
Lidocaine—Rash—Losartan—type 2 diabetes mellitus	6.04e-05	0.000546	CcSEcCtD
Lidocaine—Dermatitis—Losartan—type 2 diabetes mellitus	6.03e-05	0.000546	CcSEcCtD
Lidocaine—Headache—Losartan—type 2 diabetes mellitus	6e-05	0.000543	CcSEcCtD
Lidocaine—Asthenia—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000533	CcSEcCtD
Lidocaine—Nausea—Losartan—type 2 diabetes mellitus	5.69e-05	0.000515	CcSEcCtD
Lidocaine—Dizziness—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000491	CcSEcCtD
Lidocaine—Vomiting—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000472	CcSEcCtD
Lidocaine—Rash—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000469	CcSEcCtD
Lidocaine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000468	CcSEcCtD
Lidocaine—Headache—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000466	CcSEcCtD
Lidocaine—Nausea—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000441	CcSEcCtD
Lidocaine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	2.56e-06	2.88e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	2.54e-06	2.85e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.53e-06	2.84e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	2.52e-06	2.84e-05	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.52e-06	2.84e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.52e-06	2.83e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.5e-06	2.82e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.49e-06	2.8e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	2.49e-06	2.8e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	2.49e-06	2.8e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.49e-06	2.8e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.48e-06	2.79e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.48e-06	2.79e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	2.48e-06	2.79e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	2.47e-06	2.77e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.46e-06	2.77e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.46e-06	2.77e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SRC—type 2 diabetes mellitus	2.46e-06	2.77e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—INS—type 2 diabetes mellitus	2.45e-06	2.76e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.43e-06	2.74e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.43e-06	2.73e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.43e-06	2.73e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.43e-06	2.73e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	2.42e-06	2.72e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.42e-06	2.72e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.41e-06	2.71e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	2.4e-06	2.7e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.38e-06	2.68e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	2.38e-06	2.68e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	2.38e-06	2.68e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.37e-06	2.67e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.37e-06	2.67e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.37e-06	2.67e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.36e-06	2.65e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	2.36e-06	2.65e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	2.35e-06	2.64e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.34e-06	2.64e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.34e-06	2.63e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.33e-06	2.62e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.32e-06	2.61e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.32e-06	2.61e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.32e-06	2.6e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.31e-06	2.6e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.31e-06	2.59e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.3e-06	2.58e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	2.28e-06	2.57e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—SRC—type 2 diabetes mellitus	2.27e-06	2.56e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.27e-06	2.55e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.27e-06	2.55e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.27e-06	2.55e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.26e-06	2.54e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.26e-06	2.54e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.25e-06	2.53e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.23e-06	2.51e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.23e-06	2.5e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.22e-06	2.5e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.19e-06	2.47e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.19e-06	2.46e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	2.45e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	2.45e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	2.18e-06	2.45e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.17e-06	2.44e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.15e-06	2.42e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.15e-06	2.42e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.14e-06	2.41e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.14e-06	2.41e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.14e-06	2.41e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.14e-06	2.41e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.14e-06	2.41e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.14e-06	2.4e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.13e-06	2.4e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.13e-06	2.39e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.12e-06	2.39e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.12e-06	2.39e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.11e-06	2.38e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.11e-06	2.37e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.1e-06	2.37e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.1e-06	2.37e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.1e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.1e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.1e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.09e-06	2.35e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.09e-06	2.35e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.09e-06	2.35e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.08e-06	2.34e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.08e-06	2.33e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.07e-06	2.33e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.05e-06	2.3e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.04e-06	2.3e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.04e-06	2.29e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—type 2 diabetes mellitus	2.03e-06	2.28e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.03e-06	2.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	2.03e-06	2.28e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.02e-06	2.28e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.02e-06	2.28e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.02e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.01e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.01e-06	2.26e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2e-06	2.25e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2e-06	2.25e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	2e-06	2.24e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.99e-06	2.24e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.99e-06	2.23e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.97e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.97e-06	2.21e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.97e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.96e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.95e-06	2.19e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.94e-06	2.18e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.93e-06	2.17e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.91e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.9e-06	2.14e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.89e-06	2.13e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.88e-06	2.12e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.87e-06	2.11e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.87e-06	2.11e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.87e-06	2.11e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-06	2.09e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.85e-06	2.08e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.84e-06	2.07e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.84e-06	2.07e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.84e-06	2.06e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.83e-06	2.06e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.83e-06	2.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.83e-06	2.05e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.82e-06	2.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.81e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.81e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.81e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.81e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.81e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.8e-06	2.02e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.78e-06	2e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.78e-06	2e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.77e-06	1.99e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.76e-06	1.98e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.76e-06	1.98e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.75e-06	1.97e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.74e-06	1.96e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.74e-06	1.96e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.73e-06	1.95e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.73e-06	1.95e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.73e-06	1.94e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.73e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.72e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-06	1.94e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.71e-06	1.93e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.71e-06	1.93e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.71e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.71e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.7e-06	1.91e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.69e-06	1.9e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.69e-06	1.9e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.68e-06	1.89e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.67e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.67e-06	1.87e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—type 2 diabetes mellitus	1.66e-06	1.86e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.65e-06	1.86e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.65e-06	1.86e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	1.85e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.64e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.63e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.63e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.62e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.62e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.62e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.62e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.61e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.61e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.61e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.6e-06	1.8e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	1.59e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.57e-06	1.77e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.57e-06	1.76e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.56e-06	1.75e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.55e-06	1.74e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.55e-06	1.74e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—type 2 diabetes mellitus	1.53e-06	1.72e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—type 2 diabetes mellitus	1.53e-06	1.72e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.51e-06	1.7e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.49e-06	1.68e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.49e-06	1.68e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.49e-06	1.67e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.48e-06	1.67e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.46e-06	1.64e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.42e-06	1.6e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.42e-06	1.6e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.41e-06	1.59e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—type 2 diabetes mellitus	1.41e-06	1.59e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.41e-06	1.59e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.4e-06	1.57e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.4e-06	1.57e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.4e-06	1.57e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.39e-06	1.57e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.39e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.38e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.38e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.37e-06	1.55e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.37e-06	1.54e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.36e-06	1.53e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.36e-06	1.53e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.33e-06	1.5e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-06	1.46e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-06	1.46e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.3e-06	1.46e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.28e-06	1.44e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.27e-06	1.43e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.27e-06	1.43e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.25e-06	1.4e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.24e-06	1.4e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.22e-06	1.38e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.22e-06	1.38e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.21e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.21e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.21e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.21e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.2e-06	1.34e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-06	1.34e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.18e-06	1.33e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.15e-06	1.29e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.13e-06	1.27e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-06	1.26e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.11e-06	1.25e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	1.23e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.09e-06	1.23e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.08e-06	1.22e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.07e-06	1.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-06	1.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.07e-06	1.2e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.06e-06	1.19e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.04e-06	1.17e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.04e-06	1.17e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	1.13e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.89e-07	1.11e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	9.48e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.3e-07	1.05e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.12e-07	1.03e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.37e-07	9.41e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	8.09e-07	9.1e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8e-07	9e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8e-07	9e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	7.91e-07	8.9e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.32e-07	8.23e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	6.85e-07	7.71e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.97e-07	6.71e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.63e-07	6.33e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.58e-07	6.27e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.77e-07	5.36e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.68e-07	4.14e-06	CbGpPWpGaD
